Dr. David F. Kronn, MD

Dr. Kronn practices at Westchester Medical Center in Valhalla, New York, part of Westchester Medical Center Health Network.

Dr. Kronn's NPI, 1619979697, was assigned on August 10, 2005. Dr. Kronn graduated from University of Dublin Trinity College in 1989. Dr. Kronn holds New York license 193350.

Dr. Kronn's primary practice is Westchester Medical Center, at 100 Woods Rd, Valhalla, NY 10595 in Westchester County. The practice phone is (914) 493-7000.

Dr. Kronn's primary practice is Westchester Medical Center in Valhalla, New York, part of Westchester Medical Center Health Network. The medical group on file is Westchester Medical Center Advanced Physician Services. Dmand AI also links Dr. Kronn to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kronn practices, 3 sites in all. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Kronn's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Kronn is licensed in New York.

CMS data shows 11 Medicare services from Dr. Kronn across 1 procedure code in 2024, all of them office visits, for 28 Medicare patients. Medicare paid $1,501 for them. Every service was in an office.

CMS counts 28 Medicare patients who saw Dr. Kronn in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high cholesterol, and 57% have high blood pressure. 57% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kronn's median patient age at 14, with 51% women.

In 2024, Dr. Kronn wrote 140 Medicare Part D claims. 89% of them were for generic drugs. CMS names the drug for 121 of them, across 4 drugs with 11 or more claims each, at $816,091 in total drug cost. In 2023, CMS named 135 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kronn for performance year 2024, reported as part of a group. Dr. Kronn accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 18 papers to Dr. Kronn, published from 2016 to 2025. 2017 was the busiest year, with 4. The most frequent topics are Glycogen Storage Disease Type II, Enzyme Replacement Therapy and Neonatal Screening. Dr. Kronn has published most often in Genet Med. Dr. Kronn's most frequent co-authors are Priya S. Kishnani, Susan Sparks, MD and Sihoun Hahn, MD, PhD.

Dmand AI links Dr. Kronn to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Glycogen Storage Disease Type II and Glycogen Storage Disease. Genzyme, a Sanofi Company sponsors the most, 2. Open Payments lists research payments to Dr. Kronn that name 2 trials.

CMS Open Payments shows 289 general payments to Dr. Kronn from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 48% of the total. Sanofi and Genzyme US Companies paid the most, $143,584. It also lists 30 research payments totaling $12,814 from 2019 to 2023, naming 2 clinical trials.

Dr. Kronn graduated from University of Dublin Trinity College in 1989.